| Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice V Castagné, P Moser, S Roux, RD Porsolt Current Protocols in Neuroscience 55 (1), 8.10A.1-8.10A.14, 2011 | 808 | 2011 |
| Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. PM Moran, LS Higgins, B Cordell, PC Moser Proceedings of the National Academy of Sciences 92 (12), 5341-5345, 1995 | 451 | 1995 |
| The pharmacology of latent inhibition as an animal model of schizophrenia PC Moser, JM Hitchcock, S Lister, PM Moran Brain Research Reviews 33 (2-3), 275-307, 2000 | 265 | 2000 |
| An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone PC Moser Psychopharmacology 99, 48-53, 1989 | 237 | 1989 |
| Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area E Charpantier, P Barnéoud, P Moser, F Besnard, F Sgard Neuroreport 9 (13), 3097-3101, 1998 | 195 | 1998 |
| Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse V Castagné, RD Porsolt, P Moser European journal of pharmacology 616 (1-3), 128-133, 2009 | 157 | 2009 |
| Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies A Blondel, DJ Sanger, PC Moser Psychopharmacology 149, 293-305, 2000 | 154 | 2000 |
| Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function MG Palfreyman, CJ Schmidt, SM Sorensen, MW Dudley, JH Kehne, ... Psychopharmacology 112, S60-S67, 1993 | 148 | 1993 |
| SL65.0155, a novel 5-hydroxytryptamine4 receptor partial agonist with potent cognition-enhancing properties PC Moser, OE Bergis, S Jegham, A Lochead, E Duconseille, ... Journal of Pharmacology and Experimental Therapeutics 302 (2), 731-741, 2002 | 138 | 2002 |
| Behavioral indices in antipsychotic drug discovery RD Porsolt, PC Moser, V Castagné Journal of Pharmacology and Experimental Therapeutics 333 (3), 632-638, 2010 | 130 | 2010 |
| Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist PC Moser, PM Moran, RA Frank, JH Kehne Behavioural brain research 73 (1), 163-167, 1995 | 123 | 1995 |
| Characterization of MDL 73005EF as a 5‐HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8‐OH‐DPAT and diazepam PC Moser, MD Tricklebank, DN Middlemiss, AK Mir, MF Hibert, JR Fozard British journal of pharmacology 99 (2), 343-349, 1990 | 110 | 1990 |
| Behavioral assessment of antidepressant activity in rodents V Castagné, P Moser, RD Porsolt Methods of behavior analysis in neuroscience, 2nd ed.(Buccafusco, JJ ed …, 2009 | 107 | 2009 |
| Quantitative motor assessment in FALS mice: a longitudinal study P Barnéoud, J Lolivier, DJ Sanger, B Scatton, P Moser Neuroreport 8 (13), 2861-2865, 1997 | 98 | 1997 |
| Effects of clozapine on latent inhibition in the rat PM Moran, TR Fischer, JM Hitchcock, PC Moser Behavioural Pharmacology 7 (1), 42-48, 1996 | 91 | 1996 |
| Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies JJ Lynch III, V Castagné, PC Moser, SW Mittelstadt Journal of pharmacological and toxicological methods 64 (1), 74-80, 2011 | 90 | 2011 |
| Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT3 receptors RC Miller, M Galvan, MW Gittos, PLM van Giersbergen, PC Moser, ... Drug development research 28 (1), 87-93, 1993 | 87 | 1993 |
| Preclinical behavioral models for predicting antipsychotic activity V Castagné, PC Moser, RD Porsolt Advances in pharmacology 57, 381-418, 2009 | 84 | 2009 |
| Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets A Bespalov, T Steckler, B Altevogt, E Koustova, P Skolnick, D Deaver, ... Nature Reviews Drug Discovery 15, 516, 2016 | 73 | 2016 |
| D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats E Esneault, V Castagne, P Moser, C Bonny, M Bernaudin Neuroscience 152 (2), 308-320, 2008 | 67 | 2008 |
